Lumenis Introduces a 360Â° Solution for Womenâ€™s Gynecological Health at the 2016 International Urogynecological Association Meeting
Online PR News – 26-December-2016 – Yokne'am Illit – Enabling Gynecologists and Urogynecologists to Offer Advanced Treatments for a Variety of Gynecological and Vaginal Health Conditions and Expand their Practice Offering
Lumenis Ltd., the worldâ€™s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the introduction of FemTouchâ„˘, anenhancement to the comprehensive offering for womenâ€™s gynecological health, along with the AcuPulseâ„˘ CO2 laser product family, at the upcoming 41st Annual International Urogynecological Association (IUGA) meeting, being held in Cape Town, South Africa from August 2-6, 2016.
FemTouch, the latest addition to the AcuPulse product family, addresses vaginal health-related conditions by promoting the remodeling of the vaginal mucosal layer leading to the restoration of the vaginal canal to a premenopausal-like stage. In a series of comfortable and easy office-based treatments, each taking no more than five minutes to complete, FemTouch provides a fast and efficient solution resulting in positive outcomes after only two to four treatments, as indicated by patients around the world.
â€śMy menopause patients are so thankful for helping to restore their sex lives and relieve their vaginal dryness,â€ť said Scott Evan Eder, MD, The Center for Womenâ€™s Heath & Wellness, New Jersey. â€śOne patient said she felt 19 years old again!"
The AcuPulse CO2 laser family of products is an upgradable, all-inclusive platform providing both precision and flexibility in minimally invasive laparoscopic and colposcopy procedures in the inpatient and outpatient domains.
Fertility and pain-related indications including endometriosis, adhesions and uterine fibroids, can be treated with ideal control over cutting, ablation and coagulation with minimal intervention to nearby tissue. The treatment results in minimal thermal damage, preservation of valuable structures and an overall enhancement of a womanâ€™s quality of life.
â€śTreating endometriosis lesions on critical intra-abdominal structures, such as the bowel, bladder, ureter and major blood vessels, can be quite challenging as one needs to avoid perforations and minimize risk of adhesion formation and other potential complications," said Ceana Nezhat, MD, FACOG, FACS, Nezhat Medical Center, Georgia. â€śUsing CO2 laser fibers during laparoscopic procedures enables us to precisely target the desired treatment areas with markedly reduced thermal damage to surrounding tissues. This new AcuPulse CO2 technology is the wave of the future in minimally invasive gynecological surgery.â€ť
â€śLumenis collaborates with leading gynecologists to develop various solutions to advance the treatment of womenâ€™s health,â€ť said Tzipi Ozer-Armon, CEO of Lumenis. â€śWith an extensive gynecological portfolio of products that offer optimal control and precision, Lumenis proudly offers women around the globe comprehensive solutions to improve their gynecological health with less post-operative morbidity, fewer disease recurrence rates and, ultimately, an improved quality of life.â€ť
To learn more about Lumenis and its wide range of gynecological solutions, please visit the Lumenis booth #38.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL), Radio-Frequency (RF) and ultrasound. For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information about vaginal dryness, visit: http://www.femtouch.com.